Microsoft loses No. 2 ranking in market value to drug maker
Microsoft has lost its status as the world’s second-largest corporation to drug maker Pfizer due to slowing sales growth that caused it to miss out on this year’s stock-market rally.
Report Says More Farmers Don’t Follow Biotech Rules
A new study, drawn from government data, shows that more farmers are failing to comply with standards governing the planting of genetically modified corn than the industry has claimed.
Nearly one-fifth of farms growing the main type of genetically engineered corn, BT corn, are violating government rules aimed at preserving the usefulness of the corn, a consumer group said yesterday.
More regulations for biotech products aren’t necessary, FDA says
Genetically engineered foods from crops that have already been reviewed and approved by two government agencies shouldn’t have to jump through a third regulatory hoop at the Food and Drug Administration, an FDA official told Congress Tuesday.
Pfizer unveils anti-smoking drug
Pfizer Inc. introduced a new anti-smoking drug Tuesday that could become one of its biggest selling products.
New Drug Rules Aim To Speed Generics
President Bush today announced new regulations to hasten the pace at which generic drugs are brought to market, a measure the administration says will save $3.5 billion annually after it takes effect Aug. 18.
RNAi Firms Stake Their Claims First there was gene splicing. Next came monoclonal antibodies. And now, RNA interference, or gene silencing, has taken the scientific community by storm. Reportedly, RNA interference technology has revolutionized the practice of molecular biology – and the excitement it has generated continues to mount
More U.S. Investment in Biotech Needed, USAID Chief Says The United States and the international community should continue to invest more in the development of new agricultural technologies — including biotechnology — to prevent millions more Africans from becoming malnourished and vulnerable to disease and infection, says Andrew Natsios, administrator of the U.S. Agency for International Development (USAID).
Wake Up and Smell the Science
Longer-Lasting Perfume Is One Promise As Biotechnology Heads for Store Shelves
Biotech Investors: When Will They Ever Learn?
Investors should get a grip on reality. Many small companies that were lifted on the latest news are strapped for cash and pursuing risky science that will take years to bear fruit. Even for big players, good trial data on a drug don’t guarantee Food & Drug Administration approval. And once drugs do get approved, most of them face competition in the market.
Drug ads deliver a few side effects Drug companies tripled their advertising budgets in recent years to acquaint American consumers with things like acid reflux disease, depression, erectile dysfunction, and even toenail fungus, a marketing blitz that accounted for roughly 12 percent of the growth in national prescription drug spending in 2000, according to a Harvard University-MIT study released yesterday.